[1]
“Association of Serum Ferritin with Metabolic Syndrome, Insulin Resistance, Dyslipidemia, and Abdominal Obesity: A Systematic Review”., World Journal of Current Med and Pharm Research, vol. 8, no. 3, pp. 318–322, Nov. 2026, doi: 10.37022/wjcmpr.v8i3.477.